ArticleAIDS and behavior2026
Delay, Doubt and Dollars: Exploring Delay and Probability Discounting of Free and Paid HIV Vaccines among Sexual and Gender Minorities.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated how delays and uncertainties shape the perceived value of hypothetical HIV vaccines under different cost conditions among sexual and gender minorities (SGMs). In Experiment 1 (N = 260), participants chose between a 60% effective vaccine available immediately and a 99% effective vaccine with varying delays. Experiment 2 (N = 246) assessed choices between a 55% effective vaccine with certain availability and a 95% effective vaccine with uncertain availability. Participants were randomly assigned to free or $150 fee conditions. Hyperbolic discounting models effectively described delay (R² = 0.96-0.99) and probability discounting (R² = 0.95-0.99). Vaccine cost did not significantly affect discounting, while age and STI testing history did, with effects varying by delay versus probability context. Gay or bisexual identity, health insurance status, and political orientation additionally predicted probability discounting. The findings demonstrate the utility of behavioral economic models for quantifying HIV vaccine valuation prior to market availability.
Indexed as
Identifiers
42018108What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.